This is unpublished

John A.

he, him, his
Physician & Research Faculty
Professor, Division of Medical Oncology, University of Washington
Professor, Clinical Research Division, Fred Hutchinson Cancer Research Center
Medical Director, Phase 1 Clinical Trials Program, Seattle Cancer Care Alliance
Sites of Practice
Seattle Cancer Care Alliance

Photo: SCCA

Education, Training, Board Certifications 

  • M.D., University of Alabama 
  • Residency, UW 
  • Fellowship, UW 
  • Medical Oncology, American Board of Internal Medicine 
  • Internal Medicine, American Board of Internal Medicine 

Clinical Expertise

  • Skin cancer 
  • Kidney cancers 



Research and/or clinical interests  

Dr. John Thompson has devoted his career to developing better ways to treat kidney cancer and melanoma. His clinical research efforts focus on novel therapies such as cancer immunotherapy using activated lymphocytes, cytokines, and antibodies. Dr. Thompson leads the Phase 1 Clinical Trials Program at Seattle Cancer Care Alliance. Researchers in this program work with biotechnology and pharmaceutical firms to develop novel therapies for patients with cancer. Dr. Thompson’s goal is to speed the translation of experimental approaches into clinically useful therapies to improve the lives of patients.